Microcapsules engineered to support mesenchymal stem cell (MSC) survival and proliferation enable long-term retention of MSCs in infarcted myocardium

Biomaterials

Volumn 53, Issue , 2015, Pages 12-24

  Blocki, Anna ^a   Beyer, Sebastian ^b   Dewavrin, Jean Yves ^c,d   Goralczyk, Anna ^d   Wang, Yingting ^c,d   Peh, Priscilla ^d   Ng, Michael ^a   Moonshi, Shehzahdi S ^a   Vuddagiri, Susmitha ^a   Raghunath, Michael ^c,d   Martinez, Eliana C ^e   Bhakoo, Kishore K ^a,e  

^a AGENCY FOR SCIENCE   (Singapore)

^b SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Biocompatibility; Cell encapsulation; Cell therapy; Foreign body response; Invivo cell tracking; Myocardial infarction

Indexed keywords

BIOCOMPATIBILITY; FLOWCHARTING; IRON OXIDES; MAGNETIC NANOPARTICLES; MICROSTRUCTURE; STEM CELLS; SULFUR COMPOUNDS;

CELL ENCAPSULATIONS; CELL THERAPY; CELL TRACKING; FOREIGN BODY RESPONSE; MYOCARDIAL INFARCTION;

CELL CULTURE;

AGAROSE; CARBOHYDRATE; COLLAGEN TYPE 1; DEXTRAN SULFATE; FIBRINOGEN; GLYCOSAMINOGLYCAN; POLYCARBOHYDRATE; SCLEROPROTEIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; MICROCAPSULE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DENSITY; CELL ENCAPSULATION; CELL ENGINEERING; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY ASSAY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LONG TERM SURVIVAL; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROCAPSULE; MICROENVIRONMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOBLAST; PRIORITY JOURNAL; RAT; ANIMAL; CYTOLOGY; MESENCHYMAL STROMA CELL; PATHOLOGY; WISTAR RAT;

ANIMALS; CAPSULES; CELL PROLIFERATION; CELL SURVIVAL; MALE; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR;

EID: 84927939775     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.02.075     Document Type: Article

References (55)

1. Dimarino A.M., Caplan A.I., Bonfield T.L. Mesenchymal stem cells in tissue repair. Front Immunol 2013, 4201.
2. Hass R., Kasper C., Böhm S., Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal CCS 2011, 912.
3. Rangappa S., Makkar R., Forrester J. Review article: current status of myocardial regeneration: new cell sources and new strategies. JCardiovasc Pharmacol Ther 2010, 15(4):338-343.
4. Przybyt E., Harmsen M.C. Mesenchymal stem cells: promising for myocardial regeneration?. Curr Stem Cell Res Ther 2013, 8(4):270-277.
5. Abbott Alison Study queries early-phase trials of heart-disease treatment. Nature 2014, 509(7498):15-16.
6. Paul A., Ge Y., Prakash S., Shum-Tim D. Microencapsulated stem cells for tissue repairing: implications in cell-based myocardial therapy. Regen Med 2009, 4(5):733-745.
7. Al Kindi A.H., Asenjo J.F., Ge Y., Chen G.Y., Bhathena J., Chiu R.C.J., et al. Microencapsulation to reduce mechanical loss of microspheres: implications in myocardial cell therapy. Eur J Cardiothorac Surg 2011, 39(2):241-247.
8. Radisic M., Christman K.L. Materials science and tissue engineering: repairing the heart. Mayo Clin Proc 2013, 88(8):884-898.
9. Díaz-Herráez P., Garbayo E., Simón-Yarza T., Formiga F.R., Prosper F., Blanco-Prieto M.J. Adipose-derived stem cells combined with neuregulin-1 delivery systems for heart tissue engineering. Eur J Pharm Biopharm 2013, 85(1):143-150.
10. Sugiura S., Oda T., Izumida Y., Aoyagi Y., Satake M., Ochiai A., et al. Size control of calcium alginate beads containing living cells using micro-nozzle array. Biomaterials 2005, 26(16):3327-3331.
11. Ross C.J.D., Chang P.L. Development of small alginate microcapsules for recombinant gene product delivery to the rodent brain. JBiomater Sci Polym Ed 2002, 13(8):953-962.
12. Bidarra S.J., Barrias C.C., Granja P.L. Injectable alginate hydrogels for cell delivery in tissue engineering. Acta Biomater 2014, 10(4):1646-1662.
13. De Vos P., De Haan B.J., Wolters G.H., Strubbe J.H., Van Schilfgaarde R. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 1997, 40(3):262-270.
14. Uludag H., De Vos P., Tresco P.A. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev 2000, 42(1-2):29-64.
15. Vériter S., Mergen J., Goebbels R.M., Aouassar N., Grégoire C., Jordan B., et al. Invivo selection of biocompatible alginates for islet encapsulation and subcutaneous transplantation. Tissue Eng Part A 2010, 16(5):1503-1513.
16. Bryers J.D., Giachelli C.M., Ratner B.D. Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts. Biotechnol Bioeng 2012, 109(8):1898-1911.
17. Franz S., Rammelt S., Scharnweber D., Simon J.C. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011, 32(28):6692-6709.
18. Ratner B.D. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. JControl Release 2002, 78(1-3):211-218.
19. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20(2):86-100.
20. Morais J.M., Papadimitrakopoulos F., Burgess D.J. Biomaterials/tissue interactions: possible solutions to overcome foreign body response. AAPS J 2010, 12(2):188-196.
21. Baker D.W., Zhou J., Tsai Y.T., Patty K.M., Weng H., Tang E.N., et al. Development of optical probes for invivo imaging of polarized macrophages during foreign body reactions. Acta Biomater 2014, 10(7):2945-2955.
22. Wolf M.T., Dearth C.L., Ranallo C.A., LoPresti S.T., Carey L.E., Daly K.A., et al. Macrophage polarization in response to ECM coated polypropylene mesh. Biomaterials 2014, 35(25):6838-6849.
23. Williams D.F. On the nature of biomaterials. Biomaterials 2009, 30(30):5897-5909.
24. Varoni E., Tschon M., Palazzo B., Nitti P., Martini L., Rimondini L. Agarose gel as biomaterial or scaffold for implantation surgery: characterization, histological and histomorphometric study on soft tissue response. Connect Tissue Res 2012, 53(6):548-554.
25. Hernández R.M.A., Orive G., Murua A., Pedraz J.L. Microcapsules and microcarriers for in situ cell delivery. Adv Drug Deliv Rev 2010, 62(7-8):711-730.
26. Brodbeck W.G., Patel J., Voskerician G., Christenson E., Shive M.S., Nakayama Y., et al. Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates invivo. Proc Natl Acad Sci USA 2002, 99(16):10287-10292.
27. Geiger B., Bershadsky A., Pankov R., Yamada K.M. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2001, 2(11):793-805.
28. Censi R., Di Martino P., Vermonden T., Hennink W.E. Hydrogels for protein delivery in tissue engineering. JControl Release 2012, 161(2):680-692.
29. Laurens N., Koolwijk P., de Maat M.P.M. Fibrin structure and wound healing. JThromb Haemost 2006, 4(5):932-939.
30. Karoubi G., Ormiston M.L., Stewart D.J., Courtman D.W. Single-cell hydrogel encapsulation for enhanced survival of human marrow stromal cells. Biomaterials 2009, 30(29):5445-5455.
31. Chen Z., Wang L., Stegemann J.P. Phase-separated chitosan-fibrin microbeads for cell delivery. JMicroencapsul 2011, 28(5):344-352.
32. Frantz C., Stewart K.M., Weaver V.M. The extracellular matrix at a glance. JCell Sci 2010, 123(Pt 24):4195-4200.
33. Chen C., Loe F., Blocki A., Peng Y., Raghunath M. Applying macromolecular crowding to enhance extracellular matrix deposition and its remodeling invitro for tissue engineering and cell-based therapies. Adv Drug Deliv Rev 2011, 63(4-5):277-290.
34. Dewavrin J.Y., Hamzavi N., Shim V.P.W., Raghunath M. Tuning the architecture of three-dimensional collagen hydrogels by physiological macromolecular crowding. Acta Biomater 2014, 10(10):4351-4359.
35. Blocki A., Wang Y., Koch M., Peh P., Beyer S., Law P., et al. Not all MSCs can act as pericytes: functional invitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. Stem Cells Dev 2013, 22(17):2347-2355.
36. Ang X.M., Lee M.H.C., Blocki A., Chen C., Ong L.S., Asada H.H., et al. Macromolecular crowding amplifies adipogenesis of human bone marrow-derived MSCs by enhancing the pro-adipogenic microenvironment. Tissue Eng Part A 2014, 20(5-6):966-981.
37. Mathiasen A.B., Hansen L., Friis T., Thomsen C., Bhakoo K., Kastrup J. Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells. Stem cells Int 2013, 2013353105.
38. Chapon C., Jackson J.S., Aboagye E.O., Herlihy A.H., Jones W.A., Bhakoo K.K. An invivo multimodal imaging study using MRI and PET of stem cell transplantation after myocardial infarction in rats. Mol Imaging Biol 2009, 11(1):31-38.
39. Silver F.H., Birk D.E. Kinetic analysis of collagen fibrillogenesis: I. Use of turbidity-time data. Coll Relat Res 1983, 3(5):393-405.
40. Jawerth L.M., Münster S., Vader D.A., Fabry B., Weitz D.A. Ablind spot in confocal reflection microscopy: the dependence of fiber brightness on fiber orientation in imaging biopolymer networks. Biophys J 2010, 98(3):L1-L3.
41. Caplan A.I. Why are MSCs therapeutic? New data: new insight. JPathol 2009, 217(2):318-324.
42. Raghunath M., Sy Wong Y., Farooq M., Ge R. Pharmacologically induced angiogenesis in transgenic zebrafish. Biochem Biophys Res Commun 2009, 378(4):766-771.
43. Zhang L., Cao Z., Bai T., Carr L., Ella-Menye J.R., Irvin C., et al. Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nat Biotechnol 2013, 31(6):553-556.
44. Batorsky A., Liao J., Lund A.W., Plopper G.E., Stegemann J.P. Encapsulation of adult human mesenchymal stem cells within collagen-agarose microenvironments. Biotechnol Bioeng 2005, 92(4):492-500.
45. Sayyar B., Dodd M., Wen J., Ma S., Marquez-Curtis L., Janowska-Wieczorek A., et al. Encapsulation of factor IX-engineered mesenchymal stem cells in fibrinogen-alginate microcapsules enhances their viability and transgene secretion. Jtissue Eng 2012, 3(1). 2041731412462018.
46. Tian H., Li C., Liu W., Li J., Li G. The influence of chondroitin 4-sulfate on the reconstitution of collagen fibrils invitro. Colloids Surf B Biointerfaces 2013, 105259-105266.
47. Garg A.K., Berg R.A., Silver F.H., Garg H.G. Effect of proteoglycans on type I collagen fibre formation. Biomaterials 1989, 10(6):413-419.
48. Stamov D., Grimmer M., Salchert K., Pompe T., Werner C. Heparin intercalation into reconstituted collagen I fibrils: impact on growth kinetics and morphology. Biomaterials 2008, 29(1):1-4.
49. Wheatley M.A., Moo-Young M. Degradation of polysaccharides by endo- and exoenzymes: dextran-dextranase model systems. Biotechnol Bioeng 1977, 19(2):219-223.
50. Rommerskirch W., von Figura K. Multiple sulfatase deficiency: catalytically inactive sulfatases are expressed from retrovirally introduced sulfatase cDNAs. Proc Natl Acad Sci USA 1992, 89(7):2561-2565.
51. Perez R.A., Kim M., Kim T.H., Kim J.H., Lee J.H., Park J.H., et al. Utilizing core-shell fibrous collagen-alginate hydrogel cell delivery system for bone tissue engineering. Tissue Eng Part A 2014, 20(1-2):103-114.
52. van Putten S.M., Ploeger D.T.A., Popa E.R., Bank R.A. Macrophage phenotypes in the collagen-induced foreign body reaction in rats. Acta Biomater 2013, 9(5):6502-6510.
53. Goren A., Dahan N., Goren E., Baruch L., Machluf M. Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy. FASEB J Off Publ Fed Am Soc Exp Biol 2010, 24(1):22-31.
54. Lee W.Y., Wei H.J., Lin W.W., Yeh Y.C., Hwang S.M., Wang J.J., et al. Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM. Biomaterials 2011, 32(24):5558-5567.
55. Yu J., Du K.T., Fang Q., Gu Y., Mihardja S.S., Sievers R.E., et al. The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials 2010, 31(27):7012-7020.